You are here
- Home
- Therapy Areas
- Cardiovascular
Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
- Disease
- hypercholesterolaemia
- Drug Name
- Crestor
- Generic Name
- Rosuvastatin
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- Non-Interventional Study
- Start Date
- Nov 1, 2009
- Study Name
- NIS-SA-CRE-2009/1
- Study Id
- NIS-SA-CRE-2009/1
- ClinicalTrials.gov ID
- NCT01025388
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Apr 3, 2011
- NIS-SA-CRE-2009/1.pdf (445 KB)
